“...pleasure and pain, they come and go and don't last... bear them patiently”
—Gita
Pathos InvestmentsEquity Research
Research  ›  Fact Sheets  ›  CAH

CARDINAL HEALTH INC

LISTEDNYSE
SYMBOLCAH
SIC5122
STATE OF INC.OH
FISCAL YEAR ENDSJune 30
CIK721371

WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2017–2026

REVENUES, NET INCOME AND FREE CASH FLOW BY FISCAL YEAR$ billions-10001002003002017201820192020202120222023202420252026RevenuesNet incomeFree cash flowEARNINGS AND DIVIDENDS PER SHARE$ per share-15.00-10.00-5.000.005.0010.002017201820192020202120222023202420252026EPS dilutedDividends per share

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 6/30/26

($ millions)Amount%
Total debt8,886148.0
Stockholders' equity(2,883)-48.0
Total capitalization6,003100.0

232,575,728 shares outstanding at 31 July 2026 (cover page of the 10-K filed 11 August 2026).

LONG-TERM DEBT 6/30/26

($ millions)Amount
Long-term debt, noncurrent7,004
Current maturities1,882

CAPITAL STOCK 6/30/26

Common shares authorized755,000,000
Common shares issued271,000,000
Treasury shares38,000,000
Preferred stock ($ millions)0
Outstanding at 7/31/26232,575,728

DIVIDENDS DECLARED/PAID

Fiscal yearPer share $Payout %
20262.0428.2
20252.0231.3
20242.0058.0
20231.98157.1
20221.96–

HISTORY AND BUSINESS

HISTORY: Incorporated in Ohio. Formerly known as CARDINAL DISTRIBUTION INC (to 17 February 1994).

BUSINESS: Classified by the SEC under Standard Industrial Classification 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. Large accelerated filer. Principal executive office: 7000 Cardinal Place, Dublin, OH 43017. Fiscal year ends June 30. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)6/30/266/30/256/30/24
Revenues254,248222,578226,827
Cost of revenues244,474214,410219,413
Gross profit9,7748,1687,414
Selling, general and administrative6,1325,3825,000
Depreciation and amortization956790710
Operating income2,6132,2751,243
Interest expense34821551
Income before income taxes2,1742,1011,201
Income taxes469532348
Net income1,7141,561852
Earned per share, diluted ($)7.236.453.45
Dividends per share ($)2.042.022.00

CONSOLIDATED BALANCE SHEET

($ millions)6/30/266/30/25
Cash and equivalents4,8563,874
Receivables, net13,81513,242
Inventories17,29716,831
Total current assets38,75336,373
Property, plant and equipment, net3,0312,858
Goodwill11,4429,691
Total assets57,29953,122
Total current liabilities43,90438,897
Long-term debt7,0047,977
Stockholders' equity(2,883)(2,781)
Total liabilities and equity57,29953,122

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year endedRevenuesOper. incomeNet incomeNet margin %EPS diluted $Div. per share $Oper. cash flowCapital expend.Free cash flowTotal assetsTotal liabilitiesTotal debtStockholders' equityROE %Debt / equity
6/30/26254,2482,6131,7140.77.232.045,1746494,52557,29960,023d8,886(2,883)-59.5-3.08
6/30/25222,5782,2751,5610.76.452.022,3975471,85053,12255,756d8,527(2,781)-56.1-3.07
6/30/24226,8271,2438520.43.452.003,7625113,25145,12148,333d5,092(3,213)-26.5-1.58
6/30/23204,9797523300.21.261.982,8444812,36343,34946,306d4,701(2,958)-11.2-1.59
6/30/22181,326(607)(938)-0.5(3.37)1.963,1753872,78843,87844,760d5,315(709)132.3-7.50
6/30/21162,4674726110.42.081.942,4294002,02944,45342,830d6,2361,79134.13.48
6/30/20152,922(4,098)(3,696)-2.4(12.61)1.921,9603751,58540,76638,974d6,7751,789-206.63.79
6/30/19145,5342,0601,3630.94.531.912,7223282,39440,96334,633d8,0316,32821.51.27
6/30/18136,8091262560.20.811.852,7683842,38439,95133,892d9,0136,0594.21.49
6/30/17129,9762,1201,2881.04.031.801,18438779740,11233,284d11,2506,80818.91.65

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

CARDINAL HEALTH INC
CIK 721371 · EIN 31-0958666

PRINCIPAL OFFICE:

7000 Cardinal Place, Dublin, OH 43017
Tel.: 6147573033

INCORPORATED:

Ohio

INDUSTRY (SEC SIC CODE):

5122 · Wholesale-Drugs, Proprietaries & Druggists' Sundries

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 6/30/26, filed 11 August 2026

FORMER NAMES:

CARDINAL HEALTH INC; CARDINAL DISTRIBUTION INC

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

10/1/268-Kperiod 10/1/26
9/21/26DEF 14Aperiod 11/12/26
8/11/2610-Kperiod 6/30/26
8/11/268-Kperiod 8/11/26
8/11/268-Kperiod 8/7/26
8/5/268-Kperiod 8/4/26
4/30/2610-Qperiod 3/31/26
4/30/268-Kperiod 4/30/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2026 (filed 8/11/26) · 10-K FY2025 (filed 8/12/25) · 10-K FY2024 (filed 8/14/24) · 10-K FY2023 (filed 8/15/23) · 10-K FY2022 (filed 8/11/22) · 10-K FY2021 (filed 8/16/21) · 10-K FY2020 (filed 8/13/20) · 10-K FY2019 (filed 8/20/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.

Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.

Data from SEC filings  ·  Educational only  ·  Not investment advice